Loading company…
Proteins.1 develops enzyme-free technology to detect proteins, DNA, and RNA.
Proteins.1 is developing a physics-based, enzyme-free platform for molecular detection intended for diagnostics, biomarker research, and drug discovery. The technology originated at VTT and is aimed at research institutions, pharmaceutical companies, and biotechnology firms. Founded in 2025 and based in Espoo, Finland, the company raised EUR 4.7 million in pre-seed funding in April 2026, co-led by Lifeline Ventures and Cloudberry.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in